Toruno, Michelle A. https://orcid.org/0009-0003-3867-7594
Al-Janabi, Omar M.
Ghozy, Shereif
Kobeissi, Hassan
Kadirvel, Ramanathan
Rabinstein, Alejandro A.
Kallmes, David F.
Article History
Received: 9 February 2024
Revised: 27 March 2024
Accepted: 1 April 2024
First Online: 24 April 2024
Change Date: 21 June 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00415-024-12476-0
Declarations
:
: R.K. has the following conflicts: Research support from: Cerenovus Inc, Medtronic, Endovascular Engineering, Frontior Bio, Sensome Inc, Endomimetics, Ancure LLC, Neurogami Medical, MIVI Biosciences, Monarch Biosciences, Stryker Inc, Conway Medical, Pireus Medical, and Bionau Labs outside the submitted work. He holds the following research grants Research Grants: NIH (R01NS076491, R44NS107111, R43NS110114 and R21NS128199) and NSF (081215707) outside the submitted work. AAR serving on advisory boards for AstraZeneca, Novo Nordisk, and Boston Scientific outside the submitted work. D.F.K. holds equity in Nested Knowledge, Superior Medical Editors, and Conway Medical, Marblehead Medical and Piraeus Medical. He receives grant support from MicroVention, Medtronic, Balt, and Insera Therapeutics; has served on the Data Safety Monitoring Board for Vesalio; and received royalties from Medtronicoutside the submitted work.
: Ethics approval was not required for this study.
: Informed consent was not required for this study.